<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240305061172N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-04-08</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effectiveness of training of the theory of mind in improving the social interactions of children with autism spectrum disorder level 1</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effectiveness of remote training of the theory of mind in improving the social interactions of children with autism spectrum disorder level 1 compared to face-to-face training</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75858</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Other design features: According to the nature of the study, blinding is not  possible. However, the evaluator and statistician will not know about the allocation of the subjects, Randomization description: Due to the necessity of equal number of participants in two study groups, randomization will be done based on the blocked randomization method. For this, using the Randomization menu of the website of https://www.sealedenvelope.com (which provides researchers with a web-based block randomization tool) and considering random blocks of 2, 4 and 6 participants, the allocation of subjects to groups will be determined. For allocation concealment, Sequentially numbered, sealed, opaque envelopes (SNOSE) will be used.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Autism spectrum disorders.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: distance learning (online): Participants will be trained in mind reading concepts in 10 treatment levels for 20 sessions in 10 weeks based on a reliable source (Havlin et al., 1999; translated by Rezaei, 2019). (Number of sessions per week: 2 - Duration of each session: 20 minutes - Session audience: child + mother - Executive measures in each session: 1. Teaching exercises to the mother to guide the child in the online session and perform at home (daily for at least 45 minutes)2. Examining the video of the exercises and the mother's report on the exercises and the child's conditions at home3. Answering the mother's questions - mandatory items of each session: Mother's verbal report and at least 3 videos of 40-60 seconds (one of the best, one of the worst, and one of the usual) of performing exercises at home. Intervention 2: control group: face-to-face training (traditional method): Participants will be trained in mind reading concepts in 10 treatment levels for 20 sessions in 10 weeks based on a reliable source (Havlin et al., 1999; translated by Rezaei, 2019). (number of sessions per week: 1 - duration of each session: 40 minutes - session audience: mother + child - implementation measures in each session: 1. Performing exercises with the child2. Providing explanations of the exercises to the mother to perform at home3. Examining the mother's verbal report of the child's activity in the interval between sessions4. Answering mother's questions - the mandatory items of each session: Mother's verbal report of performing exercises at home.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Haresabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Speech Therapy,Kharazmi building, university campus, Vakilabad Blvd, Bahonar Blvd, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177949025</zip>
        <telephone>+98 51 3189 2001</telephone>
        <email>haresabadif@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Haresabadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Speech Therapy,Kharazmi building, university campus, Vakilabad Blvd, Bahonar Blvd, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177949025</zip>
        <telephone>+98 51 3189 2001</telephone>
        <email>haresabadif@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Receiving a diagnosis of Autism Spectrum Disorder, level 1 by a psychiatrist
Being within the autistic range according to the GARS-3 questionnaire
Monolingual Persian speaker
The age of children should be between 6 and 9 years old
no presence of any intellectual, auditory, visual, or other neurocognitive problems except ASD, as determined through observation and reviewing files at centers, as well as interviews with parents</inclusion_criteria>
      <agemin>6 years</agemin>
      <agemax>9 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Parents' lack of consent for their child's participation in the study
Observing the signs of parents' inability to participate in exercises and perform them at home</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F84.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Autistic disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: distance learning (online): Participants will be trained in mind reading concepts in 10 treatment levels for 20 sessions in 10 weeks based on a reliable source (Havlin et al., 1999; translated by Rezaei, 2019). (Number of sessions per week: 2 - Duration of each session: 20 minutes - Session audience: child + mother - Executive measures in each session: 1. Teaching exercises to the mother to guide the child in the online session and perform at home (daily for at least 45 minutes)2. Examining the video of the exercises and the mother's report on the exercises and the child's conditions at home3. Answering the mother's questions - mandatory items of each session: Mother's verbal report and at least 3 videos of 40-60 seconds (one of the best, one of the worst, and one of the usual) of performing exercises at home.</i_keyword>
      <i_keyword>control group: face-to-face training (traditional method): Participants will be trained in mind reading concepts in 10 treatment levels for 20 sessions in 10 weeks based on a reliable source (Havlin et al., 1999; translated by Rezaei, 2019). (number of sessions per week: 1 - duration of each session: 40 minutes - session audience: mother + child - implementation measures in each session: 1. Performing exercises with the child2. Providing explanations of the exercises to the mother to perform at home3. Examining the mother's verbal report of the child's activity in the interval between sessions4. Answering mother's questions - the mandatory items of each session: Mother's verbal report of performing exercises at home</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score of an autistic child on the Sternberg Theory of Mind Test. Timepoint: Evaluation before and after the intervention. Method of measurement: Theory of Mind Test - Sternmen.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The score of an autistic child on the Garshasebi and Elliot (1990) Social Skills Questionnaire. Timepoint: Evaluation before and after the intervention. Method of measurement: The Garshasebi and Elliot (1990) Social Skills Questionnaire.</sec_outcome>
      <sec_outcome>The score of an autistic child on the Communication Skills Checklist - Second Edition. Timepoint: Evaluation before and after the intervention. Method of measurement: The Communication Skills Checklist - Second Edition.</sec_outcome>
      <sec_outcome>The assessment of informal social interaction behaviors. Timepoint: Evaluation before and after the intervention. Method of measurement: The assessment of informal social interaction behaviors.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-03-11</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Speech therapy department, 2nd floor, Shahid Kharazmi educational building, University campus, Vakil Abad Blvd., Bahnar Blvd. Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
